Wellington Management Group LLP Sells 2,020,721 Shares of Humana Inc. (NYSE:HUM)

Wellington Management Group LLP trimmed its position in shares of Humana Inc. (NYSE:HUM) by 44.0% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 2,570,439 shares of the insurance provider’s stock after selling 2,020,721 shares during the period. Wellington Management Group LLP’s holdings in Humana were worth $652,146,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. CreativeOne Wealth LLC bought a new position in shares of Humana during the third quarter valued at approximately $208,000. Public Sector Pension Investment Board grew its position in Humana by 13.0% in the 3rd quarter. Public Sector Pension Investment Board now owns 5,222 shares of the insurance provider’s stock valued at $1,654,000 after acquiring an additional 600 shares during the last quarter. PDT Partners LLC increased its stake in Humana by 190.0% in the third quarter. PDT Partners LLC now owns 4,060 shares of the insurance provider’s stock worth $1,286,000 after purchasing an additional 2,660 shares during the period. Paloma Partners Management Co lifted its position in shares of Humana by 33.7% during the third quarter. Paloma Partners Management Co now owns 853 shares of the insurance provider’s stock worth $270,000 after purchasing an additional 215 shares during the last quarter. Finally, Concentric Capital Strategies LP purchased a new stake in shares of Humana during the third quarter valued at $6,660,000. 92.38% of the stock is owned by hedge funds and other institutional investors.

Humana Stock Down 0.1 %

Shares of Humana stock opened at $264.35 on Tuesday. The company has a quick ratio of 1.76, a current ratio of 1.76 and a debt-to-equity ratio of 0.68. The company has a market cap of $31.91 billion, a P/E ratio of 26.57, a PEG ratio of 2.05 and a beta of 0.57. The firm’s 50 day moving average price is $269.77 and its 200-day moving average price is $273.07. Humana Inc. has a 52-week low of $213.31 and a 52-week high of $406.46.

Humana (NYSE:HUM) last released its quarterly earnings results on Tuesday, February 11th. The insurance provider reported ($2.16) earnings per share (EPS) for the quarter, topping the consensus estimate of ($2.26) by $0.10. Humana had a net margin of 1.02% and a return on equity of 11.70%. On average, sell-side analysts predict that Humana Inc. will post 16.47 EPS for the current fiscal year.

Humana Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Friday, April 25th. Shareholders of record on Friday, March 28th will be issued a $0.885 dividend. This represents a $3.54 annualized dividend and a yield of 1.34%. The ex-dividend date is Friday, March 28th. Humana’s dividend payout ratio is presently 35.58%.

Analysts Set New Price Targets

Several research firms recently commented on HUM. Royal Bank of Canada reaffirmed an “outperform” rating and issued a $283.00 price target on shares of Humana in a research note on Wednesday, February 12th. Morgan Stanley decreased their price target on shares of Humana from $301.00 to $285.00 and set an “equal weight” rating for the company in a research note on Wednesday, February 12th. Truist Financial increased their price objective on Humana from $260.00 to $290.00 and gave the stock a “hold” rating in a research note on Monday, January 6th. JPMorgan Chase & Co. decreased their target price on Humana from $257.00 to $256.00 and set a “neutral” rating for the company in a research report on Tuesday, February 18th. Finally, Barclays increased their price target on Humana from $255.00 to $270.00 and gave the stock an “equal weight” rating in a research report on Thursday, February 13th. Eighteen analysts have rated the stock with a hold rating and five have issued a buy rating to the company. Based on data from MarketBeat.com, Humana has an average rating of “Hold” and an average price target of $285.68.

About Humana

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.